Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC01
- Pharmacological subgroupC01B
- Chemical subgroupC01BD
- Chemical substanceC01BD07Dronedarone
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 7 registrations
- Dronedarona Aristo 400 MG Comprimidos Recubiertos con Pelicula Efg426.20 mg · comprimido recubierto con película · Aristo Pharma Gmbh
- Dronedarona Aurovitas 400 MG Comprimidos Recubiertos con Pelicula Efg426,21 mg · comprimido recubierto con película · Aurovitas Spain, S.A.U.
- Dronedarona Aurovitas Spain 400 MG Comprimidos Recubiertos con Pelicula Efg426.20 mg · comprimido recubierto con película · Aurovitas Spain, S.A.U.
- Dronedarona Teva 400 MG Comprimidos Recubiertos con Pelicula Efg426,20 mg · comprimido recubierto con película · Teva B.V.
United States
FDA · 3 registrations
At a glance
- ATC code
- C01BD07
- ATC group
- Cardiovascular system
- Registers
- 8
- Registrations
- 19
- With their own page
- 15
- Companies
- 15
All medicines with Dronedarone
Human medicines from every register that match Dronedarone by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
19 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Asn-Dronedarone | Canada | 400 MG | Tablet | Authorised | Ascend Laboratories LTD |
| Multaq | United States | 400MG BASE | tablet | Marketed | Sanofi Aventis US |
| Dronedarona Teva 400 MG Comprimidos Recubiertos con Pelicula Efg | Spain | 426,20 mg | comprimido recubierto con película | Marketed | Teva B.V. |
| Dronedarona Aristo 400 MG Comprimidos Recubiertos con Pelicula Efg | Spain | 426.20 mg | comprimido recubierto con película | Marketed | Aristo Pharma Gmbh |
| Dronedarona Aurovitas 400 MG Comprimidos Recubiertos con Pelicula Efg | Spain | 426,21 mg | comprimido recubierto con película | Marketed | Aurovitas Spain, S.A.U. |
| Dronedarona Aurovitas Spain 400 MG Comprimidos Recubiertos con Pelicula Efg | Spain | 426.20 mg | comprimido recubierto con película | Marketed | Aurovitas Spain, S.A.U. |
| Dronedaron Pliva 400 mg filmom obložene tablete | Croatia | filmom obložena tableta | Marketed | Pliva Hrvatska d.o.o. | |
| Multaq | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Multaq 400 MG Comprimidos Recubiertos con Pelicula | Spain | 400 mg | comprimido recubierto con película | Marketed | Sanofi Winthrop Industrie |
| Multaq 400 MG Comprimidos Recubiertos con Pelicula | Spain | 400 mg | comprimido recubierto con película | Marketed | Sanofi Winthrop Industrie |
| Multaq 400 MG Comprimidos Recubiertos con Pelicula | Spain | 400 mg | comprimido recubierto con película | Marketed | Sanofi Winthrop Industrie |
| Multaq 400 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Sanofi Winthrop Industrie | |
| Multaq | Canada | 400 MG | Tablet | Marketed | Sanofi-Aventis Canada INC |
| MULTAQ® Film-coated Tablet 400mg | Singapore | 400 mg | tablet, film coated | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Multaq | Croatia | Not marketed | |||
| Dronedarone | United States | 400MG | tablet | Tentative approval | Amneal Pharms |
| Dronedarone Hydrochloride | United States | 400MG, 400MG BASE | tablet | Tentative approval | Watson Labs INC |
| Multaq | European Union | Refused | Sanofi-Aventis | ||
| Multaq | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda |